Pelthos Therapeutics Inc. (PTHS) — Cash Flow-to-Debt Ratio
Latest as of December 2025:
-0.07x
Pelthos Therapeutics Inc. (PTHS) has a Cash Flow-to-Debt Ratio of -0.07x as of December 2025, meaning its operating cash flow of $-6.25 Million could theoretically repay 0% of its total liabilities ($91.52 Million) in one year. See how financially flexible is Pelthos Therapeutics Inc. to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
-0.07x
Operating CF / Total Liabilities
Operating Cash Flow
$-6.25 Million
USD
Total Liabilities
$91.52 Million
USD
Data as of
Dec 2025
Most recent filing
Pelthos Therapeutics Inc. Cash Flow-to-Debt Ratio (2021–2025)
Historical debt coverage capacity for Pelthos Therapeutics Inc. across 5 annual periods. For the full cash flow conversion analysis, see Pelthos Therapeutics Inc. cash conversion from operations.
Annual Cash Flow-to-Debt Ratio for Pelthos Therapeutics Inc. (2021–2025)
Year-by-year debt coverage analysis for Pelthos Therapeutics Inc..
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.25x | $-22.59 Million | $91.52 Million | ▲ +82.6% |
| 2024 | -1.42x | $-5.79 Million | $4.08 Million | ▼ -845.8% |
| 2023 | -0.15x | $-981.03K | $6.54 Million | ▲ +64.0% |
| 2022 | -0.42x | $-1.57 Million | $3.76 Million | ▲ +3.8% |
| 2021 | -0.43x | $-1.59 Million | $3.68 Million | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.